CA
MDXG icon

Calton & Associates’s MiMedx Group MDXG Stock Holding History

Calton & Associates’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,534
Closed -$125K – 467
2025
Q4 		$125K Hold
18,534
– – 0.02% 435
2025
Q3 		$129K Sell
18,534
-2,900
-14% -$20.2K 0.02% 413
2025
Q2 		$131K Buy
+21,434
New +$143K 0.02% 375
2024
Q4 		– Sell
-23,234
Closed -$137K – 244
2024
Q3 		$137K Buy
+23,234
New +$154K 0.05% 230
2023
Q4 		– Sell
-24,334
Closed -$177K – 264
2023
Q3 		$177K Buy
+24,334
New +$181K 0.26% 90

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Calton & Associates's MDXG Position: Q1 2026 in Review

Calton & Associates sold out of MiMedx Group (MDXG) in Q1 2026, closing a stake of 18,534 shares — an estimated $125K sold.

Calton & Associates first reported a position in MDXG in Q3 2023 and held it in 5 quarters. The position peaked at $177K in Q3 2023. 238 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Calton & Associates reported no remaining MiMedx Group position as of Q1 2026 after selling out during the quarter.
  • Calton & Associates sold 18,534 MiMedx Group shares in Q1 2026, an estimated $125K.
  • Calton & Associates first reported a position in MiMedx Group in Q3 2023 and held it in 5 quarters.
  • Calton & Associates's MiMedx Group position peaked at $177K in Q3 2023.
  • 238 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Calton & Associates's 13F filing for Q1 2026, filed 13 May 2026.